Laura MacKinnon1, JinCheol Choi, Mary Clare Kennedy, Rupinder Brar, M-J Milloy, Kanna Hayashi, Maria Eugenia Socías. 1. British Columbia Centre on Substance Use, Vancouver, BC (LM, JC, MCK, MJM, KH, MES); University of British Columbia Department of Medicine, Vancouver, BC (MCK, MJM, MES); University of British Columbia Department of Family Practice, Vancouver, BC (LM, RB); Simon Fraser University Faculty of Health Sciences, Burnaby, BC (KH); PHS Community Services Society, Vancouver, BC (RB).
Abstract
BACKGROUND: Although factors associated with completion of medical detoxification treatment for substance use disorders (SUD) are well described, there is limited information on barriers and facilitators to subsequent linkage to SUD treatment in the community. This study aimed to evaluate correlates of successful linkage to community SUD treatment on discharge. METHODS: Data were drawn from 2 prospective cohorts of people who use unregulated drugs in Vancouver, Canada between December 2012 and May 2018. Multivariable generalized estimating equations were used to investigate factors associated with linkage to community SUD treatment in the 6-month period after attending detoxification treatment. RESULTS: Of the 264 detoxification treatment encounters contributed by 178 people who use unregulated drugs, these were most often (n = 104, 39%) related to polysubstance use, and the majority (n = 174, 66%) resulted in subsequent linkage to community treatment. In the multivariable analysis, compared to attending detoxification treatment for opioid use, attending detoxification treatment for stimulants (adjusted odds ratio [AOR] = 0.23, 95% confidence interval [CI]: 0.10-0.51) and alcohol (AOR = 0.17, 95% CI: 0.06-0.54) were associated with lower odds of subsequent linkage to community treatment. Conversely, later calendar year of detoxification treatment remained associated with higher odds (AOR = 1.23, 95% CI: 1.06-1.42). CONCLUSIONS: Only two-thirds of detoxification treatment encounters in Vancouver were subsequently linked to community SUD treatment, with those related to nonopioid substances being less likely. Findings suggest the need for tailored interventions for specific substances to improve linkage to SUD treatment in the community on discharge.
BACKGROUND: Although factors associated with completion of medical detoxification treatment for substance use disorders (SUD) are well described, there is limited information on barriers and facilitators to subsequent linkage to SUD treatment in the community. This study aimed to evaluate correlates of successful linkage to community SUD treatment on discharge. METHODS: Data were drawn from 2 prospective cohorts of people who use unregulated drugs in Vancouver, Canada between December 2012 and May 2018. Multivariable generalized estimating equations were used to investigate factors associated with linkage to community SUD treatment in the 6-month period after attending detoxification treatment. RESULTS: Of the 264 detoxification treatment encounters contributed by 178 people who use unregulated drugs, these were most often (n = 104, 39%) related to polysubstance use, and the majority (n = 174, 66%) resulted in subsequent linkage to community treatment. In the multivariable analysis, compared to attending detoxification treatment for opioid use, attending detoxification treatment for stimulants (adjusted odds ratio [AOR] = 0.23, 95% confidence interval [CI]: 0.10-0.51) and alcohol (AOR = 0.17, 95% CI: 0.06-0.54) were associated with lower odds of subsequent linkage to community treatment. Conversely, later calendar year of detoxification treatment remained associated with higher odds (AOR = 1.23, 95% CI: 1.06-1.42). CONCLUSIONS: Only two-thirds of detoxification treatment encounters in Vancouver were subsequently linked to community SUD treatment, with those related to nonopioid substances being less likely. Findings suggest the need for tailored interventions for specific substances to improve linkage to SUD treatment in the community on discharge.
Authors: Eric M Schmidt; Shalini Gupta; Thomas Bowe; Laura S Ellerbe; Tyler E Phelps; John W Finney; Steven M Asch; Keith Humphreys; Jodie Trafton; Megan Vanneman; Alex H S Harris Journal: Subst Abus Date: 2016-07-19 Impact factor: 3.716
Authors: Vitor S Tardelli; Adam Bisaga; Felipe B Arcadepani; Gilberto Gerra; Frances R Levin; Thiago M Fidalgo Journal: Psychopharmacology (Berl) Date: 2020-06-29 Impact factor: 4.530
Authors: Margaret T Lee; Maria Torres; Mary Brolin; Elizabeth L Merrick; Grant A Ritter; Lee Panas; Constance M Horgan; Nancy Lane; Jonna C Hopwood; Natasha De Marco; Andrea Gewirtz Journal: J Subst Abuse Treat Date: 2020-01-31
Authors: Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds Journal: J Subst Abuse Treat Date: 2014-05-02
Authors: Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Margaret T Lee; Lee Panas; Grant A Ritter; Kevin Campbell Journal: J Rural Health Date: 2019-05-15 Impact factor: 4.333